News
51m
MyChesCo on MSNMadrigal Licenses Oral GLP-1 Drug From CSPC, Targets Next-Gen MASH TherapyCONSHOHOCKEN, PA — Madrigal Pharmaceuticals (NASDAQ: MDGL) announced Monday it has secured exclusive global rights to develop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results